A detailed history of Richardson Financial Services Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Richardson Financial Services Inc. holds 210 shares of LGND stock, worth $39,282. This represents 0.02% of its overall portfolio holdings.

Number of Shares
210
Previous 113 85.84%
Holding current value
$39,282
Previous $12.7 Million 192.47%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$112.56 - $177.14 $10,918 - $17,182
97 Added 85.84%
210 $37.2 Million
Q2 2025

Jul 24, 2025

BUY
$96.67 - $118.22 $3,480 - $4,255
36 Added 46.75%
113 $12.7 Million
Q4 2024

Jan 24, 2025

BUY
$99.95 - $129.9 $7,696 - $10,002
77 New
77 $8.14 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.16B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Richardson Financial Services Inc. Portfolio

Follow Richardson Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richardson Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richardson Financial Services Inc. with notifications on news.